Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400085627Phase 4Not yet recruiting
Phase 4, randomised trial in postoperative delirium (POD) comparing Insulin nasal drip with Normal saline nasal drip (placebo) (2 arms). Primary endpoint: Incidence of postoperative delirium. Planned start Jun 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400085627.